Published in J Invest Dermatol on November 01, 1987
Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol (1997) 2.23
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest (1999) 1.87
The desmosome and pemphigus. Histochem Cell Biol (2008) 1.54
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest (1989) 1.26
Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture. J Clin Invest (1997) 1.23
Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol (2010) 0.87
Plasminogen mediates the pathological effects of urokinase-type plasminogen activator overexpression. Am J Pathol (2004) 0.86
p38 MAPK Signaling in Pemphigus: Implications for Skin Autoimmunity. Autoimmune Dis (2013) 0.81
Endemic pemphigus over a century: Part II. N Am J Med Sci (2010) 0.79
Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis. Am J Pathol (1997) 0.79
Expression of serine proteinases and metalloproteinases in organ-cultured human skin. Altered levels in the presence of retinoic acid and possible relationship to retinoid-induced loss of epidermal cohesion. Am J Pathol (1994) 0.78
Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann. Arch Dermatol Res (1993) 0.78
Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis. Arch Dermatol Res (1991) 0.75
Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell (2000) 6.93
Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem J (1974) 2.65
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
Role of granulocyte collagenase in collagen degradation. Am J Pathol (1972) 1.92
Cross-talk between adherens junctions and desmosomes depends on plakoglobin. J Cell Biol (1997) 1.77
Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol (1992) 1.74
Electrical injury causing ventricular arrhythmias. Br Heart J (1987) 1.74
Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med (1983) 1.73
Human granulocyte collagenase. Science (1968) 1.68
Retention and internal loading of phosphorus in shallow, eutrophic lakes. ScientificWorldJournal (2001) 1.65
Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis. Science (1977) 1.47
Anti-epidermal-cell-surface pemphigus antibody detaches viable epidermal cells from culture plates by activation of proteinase. Proc Natl Acad Sci U S A (1978) 1.47
Regulation of human natural killing. I. The role of monocytes, interferon, and prostaglandins. J Immunol (1981) 1.40
Undifferentiated keratinocytes control growth, morphology, and antigen expression of normal melanocytes through cell-cell contact. Lab Invest (1993) 1.36
Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. J Biol Chem (1983) 1.33
Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. J Invest Dermatol (1994) 1.30
Immunoinhibition of intracellular protein digestion in macrophages. J Exp Med (1973) 1.29
Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol (1986) 1.29
Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol (1982) 1.26
EGF-R dependent regulation of keratinocyte survival. J Cell Sci (1997) 1.23
Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol (1998) 1.15
Pyoderma gangrenosum: a reappraisal of associated systemic diseases. Br J Dermatol (1980) 1.14
Degradation of the epidermal-dermal junction by proteolytic enzymes from human skin and human polymorphonuclear leukocytes. J Exp Med (1984) 1.14
Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans. J Biol Chem (1987) 1.13
Lysosomes and the skin. J Invest Dermatol (1975) 1.13
Angiotensin I conversion by human and rat chymotryptic proteinases. J Invest Dermatol (1984) 1.12
Psoriasis, polymorphonuclear leukocytes, and lithium carbonate. An important clue. Arch Dermatol (1979) 1.11
Migrating keratinocytes express urokinase-type plasminogen activator. J Invest Dermatol (1987) 1.10
Proteinases of human epidermis; a possible mechanism for polymorphonuclear leukocyte chemotaxis. Biochim Biophys Acta (1976) 1.08
Real-time PCR assays compared to culture-based approaches for identification of aerobic bacteria in chronic wounds. Clin Microbiol Infect (2010) 1.08
Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis. Arch Dermatol (1972) 1.07
Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration. J Invest Dermatol (1993) 1.07
Collagenase and connective tissue metabolism in epidermolysis bullosa. J Invest Dermatol (1972) 1.06
A cytotoxic proteinase isolated from human lymphocytes. J Immunol (1978) 1.05
Role of laminin in localization of human dermal mast cells. Lab Invest (1991) 1.02
Reaction of human skin chymotrypsin-like proteinase chymase with plasma proteinase inhibitors. J Biol Chem (1989) 1.01
Collagenase in bone of man. J Histochem Cytochem (1969) 1.01
Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol (1992) 1.00
Protease activity of normal and PHA stimulated human lymphocytes. Cell Immunol (1975) 0.99
A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration. Cell Regul (1990) 0.99
Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol (1988) 0.99
E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci (1994) 0.96
mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol (1990) 0.96
In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res (1990) 0.95
Human skin proteinases as inflammatory mediators. Br J Dermatol (1983) 0.95
Cytokine-induced expression of transforming growth factor-alpha and the epidermal growth factor receptor in neonatal skin explants. J Invest Dermatol (1992) 0.95
Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol (1985) 0.94
Sore throat after operation: influence of tracheal intubation, intracuff pressure and type of cuff. Br J Anaesth (1982) 0.94
Message of nexin 1, a serine protease inhibitor, is accumulated in the follicular papilla during anagen of the hair cycle. J Cell Sci (1995) 0.93
A central role of Bcl-X(L) in the regulation of keratinocyte survival by autocrine EGFR ligands. J Invest Dermatol (1999) 0.93
Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci U S A (1997) 0.93
Narrative and procedural discourse after closed head injury. Brain Inj (1991) 0.92
Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients. J Invest Dermatol (1983) 0.92
Cellular serine proteinase induces chemotaxis by complement activation. Nature (1977) 0.92
Proteinase activation: a mechanism for cellular dyshesion in pemphigus. J Invest Dermatol (1980) 0.92
New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br J Dermatol (2011) 0.92
Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. J Clin Invest (1993) 0.91
Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science (1982) 0.90
The involvement of antigen-presenting cells and suppressor cells in the ultraviolet radiation-induced inhibition of secondary cytotoxic T cell sensitization. J Immunol (1983) 0.90
Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol (1989) 0.90
Purification and identification of two serine class proteinases from dog mast biochemically and immunologically similar to human proteinases tryptase and chymase. Arch Biochem Biophys (1988) 0.90
Neutral proteinase of rabbit skin: an enzyme capable of degrading skin protein and inducing an inflammatory response. Biochim Biophys Acta (1974) 0.89
Collagenase production by human dermis in vitro. J Invest Dermatol (1969) 0.89
Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. Ann Intern Med (1990) 0.88
Protein kinase C mediates up-regulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. J Cell Physiol (1996) 0.88
Characterization of a chemotactic and cytotoxic proteinase from human skin. Biochim Biophys Acta (1977) 0.87
Present status of pyoderma gangrenosum. Review of 21 cases. Arch Dermatol (1989) 0.87
Use of a serum-free epidermal culture model to show deleterious effects of epidermal growth factor on morphogenesis and differentiation. J Invest Dermatol (1995) 0.86
Depletion of NK by cellular immunoadsorption. J Immunol (1979) 0.86
Decreased calcium currents in motor nerve terminals of mice with Lambert-Eaton myasthenic syndrome. J Physiol (1995) 0.85
Plasminogen activator in cultured human epidermal cells. J Invest Dermatol (1983) 0.85
Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy". J Am Acad Dermatol (1985) 0.85
Human epidermal plasminogen activator. Characterization, localization, and modulation. Exp Cell Res (1985) 0.85
Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol (1994) 0.85
Venous leg ulcers: an analysis of underlying venous disease. Br J Dermatol (1993) 0.85
Epidural morphine by the caudal route for postoperative pain relief. Acta Anaesthesiol Scand (1982) 0.85
Transplantation of psoriatic skin onto nude mice. J Invest Dermatol (1983) 0.85
Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions. J Immunol (1994) 0.84
Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. J Cell Sci (1993) 0.84
Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes. J Cell Sci (1999) 0.84
Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol (1983) 0.83
Plasminogen activator inhibitor type 2 in human corneal epithelium. Invest Ophthalmol Vis Sci (1999) 0.83
Differentiating cells of murine stratified squamous epithelia constitutively express plasminogen activator inhibitor type 2 (PAI-2). Histochem Cell Biol (1998) 0.83
Epidermolysis bullosa hereditaria letalis: pathology, natural history and therapy. Br J Dermatol (1977) 0.83
Tissue plasminogen activator in psoriasis. J Invest Dermatol (1990) 0.82
Cathepsin D of rabbit skin: an immunoenzymic study. J Invest Dermatol (1974) 0.82
The origin of collagenase in periodontal tissues of man. J Dent Res (1969) 0.82
Immunocytochemical localization of cathepsin D in rabbit skin. Arch Dermatol (1975) 0.82
Correlation of epidermal plasminogen activator activity with disease activity in psoriasis. Br J Dermatol (1983) 0.82
Localization of plasminogen activator inhibitor type 2 (PAI-2) in hair and nail: implications for terminal differentiation. J Invest Dermatol (1998) 0.82
Pathogenesis of autoimmunity in pemphigus. Annu Rev Immunol (1985) 0.82
Activation of protein kinase C inhibits human keratinocyte migration. J Cell Physiol (1993) 0.81
Urokinase plasminogen activator is immunocytochemically detectable in squamous cell but not basal cell carcinomas. J Invest Dermatol (1992) 0.81